Propofol remains a mainstay for sedation in the intensive care unit (ICU) due to its rapid onset and short duration. However, clinicians must vigilantly monitor for propofol induced hypertriglyceridemia because the sedative is formulated in a 10% lipid emulsion. A recent descriptive cohort study evaluated 100 critically ill trauma patients. The researchers discovered that 25% of these patients developed serum triglyceride concentrations exceeding 400 mg/dL during therapy.

The study identifies the lipid injectable emulsion (ILE) dose as the most significant risk factor for this metabolic complication. Patients who developed hypertriglyceridemia received an average of 0.48 g/kg/day, compared to 0.28 g/kg/day in the control group. Notably, the relationship between the lipid dose and triglyceride concentration appears non-linear. Serum levels rise sharply once the lipid dose reaches a threshold of 0.3 to 0.4 g/kg/day.

Managing Propofol Induced Hypertriglyceridemia in Trauma Care

Effective management requires a comprehensive assessment of all intravenous caloric sources. Since propofol contributes approximately 1.1 kcal/mL from fat, it often complicates nutrition therapy goals. Consequently, ICU protocols should mandate regular triglyceride monitoring for any patient receiving continuous sedation. Standard practice involves checking levels every 48 to 72 hours for prolonged infusions.

Furthermore, trauma patients often exhibit altered metabolic states that might impair lipid clearance. Therefore, a multidisciplinary approach involving physicians and pharmacists is vital to ensure safe sedation. If triglyceride levels rise above 400 mg/dL, clinicians should consider reducing the infusion rate or transitioning to alternative agents like dexmedetomidine. Additionally, medical teams should adjust parenteral nutrition formulations to account for the calories provided by propofol.

How does propofol increase triglyceride levels?

Propofol is formulated in a lipid emulsion consisting of 10% soybean oil. This formulation provides approximately 0.1 grams of fat for every milliliter infused. Consequently, high doses or long durations can overwhelm the body's lipid clearance capacity, leading to hypertriglyceridemia.

What should clinicians do if triglycerides exceed 400 mg/dL?

When levels exceed 400 mg/dL, clinicians should evaluate the total lipid intake from all sources. Specifically, they may need to reduce the propofol dose or substitute it with non-lipid based sedatives. This action helps prevent severe complications like acute pancreatitis or propofol infusion syndrome.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. Refer to the latest local and national guidelines for clinical practice.

References

1. Lemke ES et al. Propofol-induced hypertriglyceridemia in critically ill trauma patients requiring nutrition therapy: A descriptive cohort study. JPEN J Parenter Enteral Nutr. 2026 May 17. doi: 10.1002/jpen.70105. PMID: 42143567.


2. Devaud JC et al. The Incidence of Propofol-Induced Hypertriglyceridemia and Identification of Associated Risk Factors. Crit Care Explor. 2020;2(11):e0281.


3. Compher C et al. Guidelines for the Provision of Nutrition Support Therapy in the Adult Critically Ill Patient: ASPEN. JPEN J Parenter Enteral Nutr. 2022;46(1):12-41.